ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in ProQR Therapeutics N.V. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +2 vs. Q4 2023
- Shares held
- 17.4M
- −1.00M (−5.5%) vs. Q4 2023
- Total value
- $39.8M
- +$2.82M (+7.6%) vs. Q4 2023
- New holders
- 4
- 10 more added
- Sold out
- 2
- 15 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRQR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $113.0M |
| Q1 2026 | 69 | $56.8M |
| Q4 2025 | 65 | $75.1M |
| Q3 2025 | 64 | $80.0M |
| Q2 2025 | 62 | $82.4M |
| Q1 2025 | 65 | $54.9M |
| Q4 2024 | 77 | $117.7M |
| Q3 2024 | 47 | $31.7M |
| Q2 2024 | 48 | $28.6M |
| Q1 2024 | 49 | $39.8M |
| Q4 2023 | 47 | $37.0M |
| Q3 2023 | 46 | $24.3M |
| Q2 2023 | 51 | $34.2M |
| Q1 2023 | 55 | $47.5M |
| Q4 2022 | 46 | $60.0M |
| Q3 2022 | 47 | $15.9M |
| Q2 2022 | 51 | $17.2M |
| Q1 2022 | 58 | $28.7M |
| Q4 2021 | 74 | $364.8M |
| Q3 2021 | 67 | $333.4M |
| Q2 2021 | 63 | $259.4M |
| Q1 2021 | 64 | $286.4M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding ProQR Therapeutics N.V.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $12.2M | 3.27% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 3,625,467 | $8.30M | 0.02% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 2,884,357 | $6.60M | 0.17% | −95,659−3.2% | Reduced |
| M28 Capital Management LP | 1,019,498 | $2.33M | 1.73% | −891,102−46.6% | Reduced |
| DAFNA Capital Management LLC | 905,582 | $2.07M | 0.47% | −35,000−3.7% | Reduced |
| Macquarie Group Ltd | 620,000 | $1.41M | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 483,583 | $1.10M | 0.30% | +10,958+2.3% | Added |
| Deutsche Bank AG | 385,149 | $882.0K | 0.00% | −590.0% | Reduced |
| Millennium Management LLC | 328,989 | $746.8K | 0.00% | −120,073−26.7% | Reduced |
| Monaco Asset Management SAM | 312,629 | $709.7K | 0.31% | −65,847−17.4% | Reduced |
| Two Sigma Advisers, LP | 162,000 | $371.0K | 0.00% | −6,700−4.0% | Reduced |
| Squarepoint Ops LLC | 152,502 | $346.2K | 0.00% | +24,328+19.0% | Added |
| Franklin Street Advisors Inc | 150,000 | $343.0K | 0.03% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 140,151 | $318.1K | 0.00% | +126,184+903.4% | Added |
| Bank of America Corp | 110,107 | $252.0K | 0.00% | +31,854+40.7% | Added |
| Boothbay Fund Management, LLC | 106,703 | $244.3K | 0.01% | +10,958+11.4% | Added |
| Two Sigma Investments, LP | 78,944 | $180.8K | 0.00% | −20,547−20.7% | Reduced |
| Morgan Stanley | 67,591 | $154.8K | 0.00% | −46,120−40.6% | Reduced |
| Geode Capital Management, LLC | 46,671 | $105.9K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 46,008 | $104.4K | 0.00% | −31,808−40.9% | Reduced |
| Resources Investment Advisors, LLC. | 45,000 | $103.0K | 0.00% | +13,050+40.8% | Added |
| BNP Paribas Arbitrage, SA | 35,001 | $80.1K | 0.00% | +19,100+120.1% | Added |
| RFG Advisory, LLC | 32,000 | $73.3K | 0.00% | +32,000 | New |
| Bank of Montreal | 30,000 | $73.2K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 25,943 | $59.0K | 0.00% | −8,961−25.7% | Reduced |
| Acadian Asset Management LLC | 24,763 | $56.0K | 0.00% | +24,763 | New |
| Two Sigma Securities, LLC | 23,733 | $54.3K | 0.00% | +13,096+123.1% | Added |
| JustInvest LLC | 21,429 | $49.1K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 18,334 | $42.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 17,420 | $39.9K | 0.00% | 00.0% | Unchanged |
| Atom Investors LP | 13,107 | $30.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 13,550 | $30.0K | 0.00% | +11,756+655.3% | Added |
| Advisor Group Holdings, Inc. | 12,811 | $29.1K | 0.00% | 00.0% | Unchanged |
| Occudo Quantitative Strategies LP | 12,053 | $27.6K | 0.00% | +12,053 | New |
| EP Wealth Advisors, LLC | 11,500 | $26.3K | 0.00% | +11,500 | New |
| Wells Fargo & Company | 10,996 | $25.2K | 0.00% | 00.0% | Unchanged |
| Truist Financial Corp | 10,000 | $22.9K | 0.00% | 00.0% | Unchanged |
| Csenge Advisory Group | 10,000 | $22.9K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 10,000 | $22.9K | 0.00% | 00.0% | Unchanged |
| Vontobel Holding Ltd. | 10,000 | $22.7K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 9,690 | $22.0K | 0.00% | −8,716−47.4% | Reduced |
| UBS Group AG | 4,970 | $11.4K | 0.00% | +1,070+27.4% | Added |
| BlackRock Inc. | 3,945 | $9.03K | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 4,147 | $9.00K | 0.00% | −1,713−29.2% | Reduced |
| Cutler Group LP | 4,200 | $9.00K | 0.00% | −400−8.7% | Reduced |
| JPMorgan Chase & Co | 1,493 | $3.39K | 0.00% | −321−17.7% | Reduced |
| PFS Partners, LLC | 1,000 | $2.29K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 33 | $75 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −10,085−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,536−100.0% | Sold out |